Assignee
LEGOCHEM BIOSCIENCES INC
KR·21 granted patents·10 pending applications·145 citations·filing 2012–2023
Top patents by PatentIndex Score
31 records- 0196US11173214B2Antibody-drug conjugates comprising branched linkers and methods related theretoLEGOCHEM BIOSCIENCES INC·Filed 2016·Granted Nov 16, 2021·15 cites·22 claims
- 0296US10980890B2Compounds comprising self-immolative groupLEGOCHEM BIOSCIENCES INC·Filed 2019·Granted Apr 20, 2021·12 cites·22 claims
- 0395US10183997B2Compositions and methods related to anti-CD19 antibody drug conjugatesLEGOCHEM BIOSCIENCES INC·Filed 2016·Granted Jan 22, 2019·15 cites·26 claims
- 0494US11413353B2Conjugates comprising self-immolative groups and methods related theretoLEGOCHEM BIOSCIENCES INC·Filed 2016·Granted Aug 16, 2022·11 cites·28 claims
- 0594US10118965B2Compositions and methods related to anti-EGFR antibody drug conjugatesLEGOCHEM BIOSCIENCES INC·Filed 2016·Granted Nov 6, 2018·12 cites·26 claims
- 0694US9919057B2Compounds comprising self-immolative groupLEGOCHEM BIOSCIENCES INC·Filed 2015·Granted Mar 20, 2018·20 cites·20 claims
- 0793US11167040B2Conjugates comprising peptide groups and methods related theretoLEGOCHEM BIOSCIENCES INC·Filed 2016·Granted Nov 9, 2021·9 cites·21 claims
- 0893US9993568B2Compounds comprising self-immolative groupLEGOCHEM BIOSCIENCES INC·Filed 2015·Granted Jun 12, 2018·14 cites·25 claims
- 0991US10383949B2Compounds comprising self-immolative groupLEGOCHEM BIOSCIENCES INC·Filed 2018·Granted Aug 20, 2019·9 cites·21 claims
- 1089US11975076B2Antibody-drug conjugates comprising branched linkers and methods related theretoLEGOCHEM BIOSCIENCES INC·Filed 2021·Granted May 7, 2024·1 cites·15 claims
- 1189US9669107B2Antibody-active agent conjugates and methods of useLEGOCHEM BIOSCIENCES INC·Filed 2014·Granted Jun 6, 2017·16 cites·25 claims
- 1287US11707533B2Antibody-drug conjugate comprising antibody against human ROR1 and use for the sameLEGOCHEM BIOSCIENCES INC·Filed 2020·Granted Jul 25, 2023·2 cites·38 claims
- 1386US10961242B2Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the sameLEGOCHEM BIOSCIENCES INC·Filed 2020·Granted Mar 30, 2021·2 cites·28 claims
- 1482US11654197B2Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the sameLEGOCHEM BIOSCIENCES INC·Filed 2018·Granted May 23, 2023·2 cites·18 claims
- 1581US11827703B2Compositions and methods related to anti-CD19 antibody drug conjugatesLEGOCHEM BIOSCIENCES INC·Filed 2019·Granted Nov 28, 2023·1 cites·41 claims
- 1674US10583197B2Antibody-active agent conjugates and methods of useLEGOCHEM BIOSCIENCES INC·Filed 2017·Granted Mar 10, 2020·1 cites·23 claims
- 1772US11548883B2Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the sameLEGOCHEM BIOSCIENCES INC·Filed 2018·Granted Jan 10, 2023·1 cites·13 claims
- 1872US2023272070A1Compositions and methods related to anti-cd19 antibody drug conjugatesLEGOCHEM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1971US12398124B2Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the sameLEGOCHEM BIOSCIENCES INC·Filed 2023·Granted Aug 26, 2025·0 cites·29 claims
- 2071US9951072B2Compositions and methods for inhibiting beta-lactamaseLEGOCHEM BIOSCIENCES INC·Filed 2016·Granted Apr 24, 2018·1 cites·20 claims
- 2169US2023405139A1Antibody-drug conjugate comprising antibody against human ror1 and use for the sameLEGOCHEM BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2268US9630977B2Cephalosporin derivatives and pharmaceutical compositions thereofLEGOCHEM BIOSCIENCES INC·Filed 2012·Granted Apr 25, 2017·1 cites·19 claims
- 2368US2020289662A1Antibody-active agent conjugates and methods of useLEGOCHEM BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2459US2014161829A1Antibody-active agent conjugates and methods of useLEGOCHEM BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 2559US2014187756A1Methods of preparing antibody-active agent conjugatesLEGOCHEM BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 2657US10273235B2Compositions and methods for inhibiting β-lactamaseLEGOCHEM BIOSCIENCES INC·Filed 2018·Granted Apr 30, 2019·0 cites·15 claims
- 2755US2024131178A1Antibody-drug conjugate including antibody against human cldn18.2, and use thereofLEGOCHEM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2852US2023310640A1Pyrrolobenzodiazepine derivative and ligand-linker conjugate thereofLEGOCHEM BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2950US2022226496A1Ligand-drug conjugate including linker having tris structureLEGOCHEM BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3048US2022339291A1Antibody-drug conjugates that target dlk1 and uses thereofLEGOCHEM BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3148US2022096641A1Pyrrolobenzodiazepine dimer compound with improved safety and use thereofLEGOCHEM BIOSCIENCES INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LEGOCHEM BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →